+987.9%
MRNA vs VLTO
+18.3%
+969.6%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | VLTO | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | +0.6% | +12.5% | +12.3% |
| 7D | +20.6% | +13.8% | +6.8% | +0.1% |
| 30D | +27.1% | +21.2% | +6.0% | -6.2% |
| 3M | +353.4% | +21.5% | +331.9% | +246.1% |
| 6M | +446.3% | +33.0% | +413.3% | +304.9% |
| YTD | +776.2% | +17.8% | +758.4% | +562.8% |
| 1Y | +987.9% | +18.1% | +969.8% | +718.7% |
| All | +987.9% | +18.3% | +969.6% | +718.7% |
Cumulative growth
Daily Returns
Daily percentage return beside VLTO.
Daily Out/Under-Performance
Portfolio return minus VLTO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × VLTO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded VLTO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling